Sectra (STO:SECTB) and Leica Biosystems announced that they formed a partnership to collaborate in an effort to win FDA clearance for an integrated clinical pathology solution. The companies said their goal is to address the clinical needs of enterprise-level customers, including academic medical centers, clinical research organizations and large hospital networks. They have already submitted an […]
Leica Biosystems
ZMH proposes to mollify EU anti-trust regulators on pending, $13B acquisition Biomet | The week in medtech M&A
Danaher’s Leica division closes Devicor Medical buy
